Eiger BioPharmaceuticals, Inc. of PALO ALTO, CA, a company, filed a Form D amendment with the SEC on 2009-09-10. The offering totals $24.6M, of which $21.8M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Asish Xavier | Director | South San Francisco, CA |
| Rebecque Laba | Executive Officer | San Diego, CA |
| Krisztina Zsebo | Director | San Diego, CA |
| Krisztina Zsebo | Executive Officer | San Diego, CA |
| Jeffrey S Glenn | Director | Palo Alto, CA |
| Asish R Xavier | Director | San Diego, CA |
| Graham E Cooper | Director | Brisbane, CA |
| Nina S Kjellson | Director | Palo Alto, CA |
| Joanne H Quan | Executive Officer | Palo Alto, CA |
| Charles J Bramlage | Director | Palo Alto, CA |
| Thomas J Dietz | Director | Palo Alto, CA |
| James H Welch | Executive Officer | Palo Alto, CA |
| James P Shaffer | Executive Officer | Palo Alto, CA |
| David A Cory | Director | Palo Alto, CA |
| David A Cory | Executive Officer | Palo Alto, CA |
| Eduardo Bruno Martins | Executive Officer | Palo Alto, CA |
| Edgar G Engleman | Director | Pleasanton, CA |
| Gregg E Alton | Director | San Diego, CA |
| Joshua E Funder | Director | San Diego, CA |
| Michael E Narachi | Director | San Diego, CA |
| Todd E Foley | Director | San Diego, CA |
| Fouad E Azzam | Director | San Diego, CA |
| Daniel E Omstead | Director | San Diego, CA |
| Andrew E Senyei | Director | San Diego, CA |
| Lauren E Silverman | Director | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2016-04-29 | D | $3.0M | $3.0M |
| 2013-10-25 | D | $2.4M | $1.1M |
| 2012-05-08 | D/A | $64.5M | $19.5M |
| 2012-02-06 | D | $61.3M | $17.8M |
| 2011-12-22 | D | $500K | $500K |
| 2011-11-16 | D | $500K | $330K |
| 2011-10-28 | D | $200K | $200K |
| 2011-09-01 | D | $250K | $250K |
| 2011-07-12 | D | $400K | $400K |
| 2010-10-28 | D | $4.0M | $2.5M |
| 2009-12-17 | D | $6.5M | $3.5M |